Olink is delighted to be Gold Sponsor for the British Atherosclerosis Society Annual Meeting 2018, entitled “From the Vulnerable Plaque to the Vulnerable Patient“. The meeting will be held at Queen’s College, Cambridge, UK on September 6-7, 2018. You can read more about the event and see the final agenda at the conference website.
An Olink Biomarker Symposium will also take place directly after the main conference concludes at 13.10 on Friday September 7. This is open to all delegates at the BAS Annual Meeting, and your intention to attend should be indicated when completing the online conference registration form. If you do not plan to attend the main BAS conference but are interested only in joining the Olink Biomarker Symposium, please let us know using the email link below, and add your name and institution/company information to the email body.
Agenda for the Olink Biomarker Symposium, September 7, 2018
13.10 to 13.45: Olink-sponsored lunch
13.45: Introduction from Professor Manuel Mayr (Kings’ College London)
13.45 to 14.20: “Screening for new biomarkers in patients with CAD” – Professor Lars Wallentin (Uppsala University)
Lars Wallentin, MD, PhD. is Professor of Cardiology at (and founder of) the Uppsala Clinical Research Center. He obtained his PhD from Linköping University in Sweden and has gone on to become one of the world’s leading experts on unstable coronary artery disease, and one the most highly cited cardiologists overall. Professor Wallentin has been Chairman and Principal Investigator for many national and international clinical trials for cardiac diseases treatment, and has pioneered the use of molecular biomarkers and new treatment concepts in acute coronary artery diseases. Professor Wallentin has also worked closely with the pharma and biotech industries over many years and is one of the leading proponents for the use of biomarkers for precision medicine. He was the first recipient of the highly merited Nordic Medical Prize, and was elected as a member of the Royal Swedish Academy of Sciences.
14.20 to 14.35: Q&A
14.35 to 14.50: “Olink: Protein Biomarker discovery and development” – Dr. Xavier Tait (Olink Proteomics)
14.50 to 15.00: Q&A
15.00 to 15.15: Discussion
15.15: Meeting closes
Conference delegates are also very welcome to visit the Olink Proteomics booth in the exhibition area, and talk to our knowledgeable representatives to discuss our solutions for your protein biomarker research needs.